1 row is stored for this page
| Field | Field type | Value |
|---|
| generic | String | Etodolac |
| brand | String | Lodine (US brand discontinued); generic |
| structure | File | |
| classes | List of String, delimiter: , | [[:Category:NSAIDs|Non-steroidal anti-inflammatory drug (NSAID)]] • [[:Category:Pyranocarboxylic_acid_derivatives|Pyranocarboxylic acid derivative]] |
| mechanism | String | '"`UNIQ--vote-00001269-QINU`"' Renal, GI, hypertensive, and CV effects parallel the class profile; modest COX-2 preference may underlie some literature suggesting slightly better GI tolerability than non-selective NSAIDs, though clinically the difference is small'"`UNIQ--ref-0000126A-QINU`"'. |
| uses | String | '"`UNIQ--vote-0000126B-QINU`"', '"`UNIQ--vote-0000126C-QINU`"', '"`UNIQ--vote-0000126D-QINU`"' |
| starting_dose | String | IR 200-400 mg PO every 6-8 hours; ER 400-1000 mg PO once daily |
| preparations | String | 200, 300, 400, 500 mg IR tablets/capsules; 400, 500, 600 mg ER tablets |
| fda_max | String | 1000 mg/d (osteoarthritis); 1200 mg/d (rheumatoid arthritis) |
| pill_id | Text | |
| routes | List of String, delimiter: , | Oral |
| onset | String | Analgesia within 30 minutes; full anti-inflammatory effect over days |
| duration | String | 6-8 hours (IR); 24 hours (ER) |
| halflife | String | ~7 hours'"`UNIQ--ref-0000126E-QINU`"' |
| bioavailability | String | ~100% (oral; absorption complete)'"`UNIQ--ref-0000126F-QINU`"' |
| pregnancy | String | Avoid after 20 weeks (NSAID-class FDA 2020 advisory).<sup class="pcp-cn" title="This claim needs a citation.">[[[Pharmacopedia:Citation needed|citation needed]]]</sup> |
| legal | String | [[USLegal:Prescription only|Rx-only]] in US. NSAID-class '''Boxed Warning''' for CV thrombotic events and GI bleeding'"`UNIQ--ref-00001270-QINU`"' |
